Autonomous Systems Biology Hypotheses · Whitepaper WP-005 · Adversarial Biomarker Proof
AutoResearcher-HYPO™.
Autonomous hypothesis discovery under adversarial proof.
Traditional drug target discovery takes years of manual literature synthesis and trial-and-error bench assays. AutoResearcher-HYPO™ autonomously generates mechanistic biological hypotheses and subjects them to deterministic multi-agent adversarial refutation across 47+ biological databases (Reactome, STRING, AlphaFold, JASPAR, UniProt, PubMed) within its verified safety architecture.
The 4-Step Discovery Loop
How AutoResearcher-HYPO Operates
Autonomous Hypothesis Synthesis
The system ingests multi-omic patient tensors, gene expression signatures, and clinical outcomes, autonomously identifying non-obvious disease pathways, orphan enzyme blocks, and potential synthetic lethal target pairs.
Multi-Agent Counter-Refutation
Specialized Bayesian "skeptic" sub-agents aggressively attempt to falsify the hypothesis using contradictory trial publications, negative interaction assays, and pharmacokinetic feasibility limits.
Deterministic Topology Check
Surviving hypotheses are verified against structural AlphaFold coordinate interfaces, JASPAR transcription factor binding motifs, and Reactome curated pathway hierarchies, ensuring biological plausibility.
PopSIM™ Pipeline Rescue
The candidate mechanism is deployed directly into PopSIM™ virtual patient cohorts to forecast efficacy, stratify responder sub-phenotypes, and generate an audit-ready regulatory dossier.
